333 related articles for article (PubMed ID: 19680295)
21. Lung cancer: future directions.
Lam WK; Watkins DN
Respirology; 2007 Jul; 12(4):471-7. PubMed ID: 17587411
[TBL] [Abstract][Full Text] [Related]
22. Individualized therapy for patients with non-small cell lung cancer: emerging trends and challenges.
Langer CJ
Crit Rev Oncol Hematol; 2012 Jul; 83(1):130-44. PubMed ID: 22280915
[TBL] [Abstract][Full Text] [Related]
23. Tissue sampling in lung cancer: a review in light of the MERIT experience.
Reck M; Hermes A; Tan EH; Felip E; Klughammer B; Baselga J
Lung Cancer; 2011 Oct; 74(1):1-6. PubMed ID: 21658788
[TBL] [Abstract][Full Text] [Related]
24. [Target population and predictive factors of survival and efficacy of anti-HER1/EGFR drugs].
Cadranel J
Rev Pneumol Clin; 2007 Jan; 63(1 Pt 2):2S10-1. PubMed ID: 17242637
[No Abstract] [Full Text] [Related]
25. Epidermal growth factor receptor as a target in cancer therapy.
Kim ES
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S87-95. PubMed ID: 19795581
[TBL] [Abstract][Full Text] [Related]
26. Molecular biologic staging of lung cancer.
D'Amico TA
Ann Thorac Surg; 2008 Feb; 85(2):S737-42. PubMed ID: 18222207
[TBL] [Abstract][Full Text] [Related]
27. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
28. Survival improvement in thoracic cancer: progress from the last decade and beyond.
Manegold C; Thatcher N
Lung Cancer; 2007 Aug; 57 Suppl 2():S3-5. PubMed ID: 17686443
[TBL] [Abstract][Full Text] [Related]
29. Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for nonsmall cell lung cancer: exploring a new frontier.
Sangha R; Lara PN; Mack PC; Gandara DR
Curr Opin Oncol; 2009 Mar; 21(2):116-23. PubMed ID: 19532012
[TBL] [Abstract][Full Text] [Related]
30. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
Dacic S
Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
[TBL] [Abstract][Full Text] [Related]
31. Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group.
Ausborn NL; Le QT; Bradley JD; Choy H; Dicker AP; Saha D; Simko J; Story MD; Torossian A; Lu B
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e453-64. PubMed ID: 22520478
[TBL] [Abstract][Full Text] [Related]
32. Expression of LKB1 tumor suppressor in non-small cell lung cancer determines sensitivity to 2-deoxyglucose.
Inge LJ; Coon KD; Smith MA; Bremner RM
J Thorac Cardiovasc Surg; 2009 Mar; 137(3):580-6. PubMed ID: 19258070
[TBL] [Abstract][Full Text] [Related]
33. Molecular markers for incidence, prognosis, and response to therapy.
Tong BC; Harpole DH
Surg Oncol Clin N Am; 2012 Jan; 21(1):161-75. PubMed ID: 22098838
[TBL] [Abstract][Full Text] [Related]
34. A critical appraisal of prognostic and predictive factors for common lung cancers.
Thunnissen FB; Schuurbiers OC; den Bakker MA
Histopathology; 2006 Jun; 48(7):779-86. PubMed ID: 16722925
[TBL] [Abstract][Full Text] [Related]
35. Translational studies for target-based drugs.
Nishio K; Arao T; Shimoyama T; Fujiwara Y; Tamura T; Saijo N
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():90-3. PubMed ID: 16273363
[TBL] [Abstract][Full Text] [Related]
36. Management of unfit older patients with advanced NSCLC.
Gridelli C; Maione P; Rossi A; Palazzolo G; Colantuoni G; Rossi E
Cancer Treat Rev; 2009 Oct; 35(6):517-21. PubMed ID: 19457617
[TBL] [Abstract][Full Text] [Related]
37. Toward the individualization of lung cancer therapy.
Anguiano A; Nevins JR; Potti A
Cancer; 2008 Oct; 113(7 Suppl):1760-7. PubMed ID: 18800387
[TBL] [Abstract][Full Text] [Related]
38. Multitargeted inhibitors in lung cancer: new clinical data.
Bar J; Herbst RS; Onn A
Clin Lung Cancer; 2008; 9 Suppl 3():S92-9. PubMed ID: 19419930
[TBL] [Abstract][Full Text] [Related]
39. The tissue is the issue: personalized medicine for non-small cell lung cancer.
Hirsch FR; Wynes MW; Gandara DR; Bunn PA
Clin Cancer Res; 2010 Oct; 16(20):4909-11. PubMed ID: 20926402
[TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.
Modjtahedi H; Essapen S
Anticancer Drugs; 2009 Nov; 20(10):851-5. PubMed ID: 19826350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
